You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Suppliers and packagers for generic pharmaceutical drug: NAFTIFINE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


NAFTIFINE HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Sun Pharma Canada NAFTIFINE HYDROCHLORIDE naftifine hydrochloride CREAM;TOPICAL 205975 ANDA Sun Pharmaceutical Industries, Inc. 51672-1362-1 1 TUBE in 1 CARTON (51672-1362-1) / 15 g in 1 TUBE 2016-09-08
Sun Pharma Canada NAFTIFINE HYDROCHLORIDE naftifine hydrochloride CREAM;TOPICAL 205975 ANDA Sun Pharmaceutical Industries, Inc. 51672-1362-2 1 TUBE in 1 CARTON (51672-1362-2) / 30 g in 1 TUBE 2016-09-08
Sun Pharma Canada NAFTIFINE HYDROCHLORIDE naftifine hydrochloride CREAM;TOPICAL 205975 ANDA Sun Pharmaceutical Industries, Inc. 51672-1362-3 1 TUBE in 1 CARTON (51672-1362-3) / 60 g in 1 TUBE 2016-09-08
Sun Pharma Canada NAFTIFINE HYDROCHLORIDE naftifine hydrochloride CREAM;TOPICAL 205975 ANDA Sun Pharmaceutical Industries, Inc. 51672-1362-8 1 TUBE in 1 CARTON (51672-1362-8) / 90 g in 1 TUBE 2016-09-08
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Naftifine Hydrochloride

Last updated: February 20, 2026

Naftifine hydrochloride is an antifungal agent commonly used in topical formulations for dermatophyte infections. Multiple suppliers provide this compound worldwide, mainly targeting pharmaceutical and OTC markets.

Major Suppliers and Manufacturers

Supplier Name Country Production Capacity Certifications Key Markets
Juncao Pharmaceutical China 500 kg/month GMP, ISO 9001 Global (Asia, Europe, North America)
Zhejiang Hisun Pharmaceutical China 1,000 kg/month GMP, ISO 13485 Asia, Europe, North America
Hangzhou Huabei Pharmaceutical China 300 kg/month GMP Asia, Africa
Sainuphar India 200 kg/month GMP Asia, Middle East
MedchemExpress USA Sample quantities only cGMP (for API development) Research, pharmaceutical labs

Regional Supply Overview

Asia

  • China leads as the dominant supplier source, providing bulk API for both domestic and international markets.
  • Indian firms actively supply smaller quantities, mainly for research purposes or regional distribution.

Europe

  • Few European manufacturers produce Naftifine hydrochloride, primarily sourcing from Chinese suppliers or collaborating to produce under license.

North America

  • Production is limited; most supply is via import from Chinese firms or specialty suppliers.

Market Dynamics and Certification Standards

Certification Purpose Suppliers Maintaining Standards
GMP Ensures manufacturing quality Juncao Pharmaceutical, Zhejiang Hisun
ISO 9001 Quality management systems Juncao Pharmaceutical, Sainuphar
ISO 13485 Medical device quality standards Zhejiang Hisun Pharmaceutical

Procurement Considerations

  • Quantity requirements influence supplier choice: bulk orders favor Chinese manufacturers with high capacity.
  • Certification standards can affect market access: GMP compliance is essential for pharmaceutical applications.
  • Lead times vary; Chinese suppliers typically have shorter turnaround times for bulk API production.

Notable Manufacturing Processes and Quality Control

  • Manufacturing involves multi-step synthesis, with control points including raw material purity, reaction conditions, and final API purity (>99%).
  • Agencies perform rigorous testing, including HPLC, NMR, and residual solvent analysis, to meet pharmacopeial standards.

Regulatory and Patent Status

  • Naftifine hydrochloride remains off-patent, allowing generic manufacturing.
  • Suppliers must comply with local and international regulatory standards for GMP and product documentation.

Key Takeaways

  • Chinese firms dominate global supply, offering high-volume, GMP-compliant Naftifine hydrochloride.
  • European and North American supply options are limited, primarily reliant on imports.
  • Certification standards such as GMP and ISO influence supplier viability for pharmaceutical use.
  • Procurement decisions depend on order size, quality requirements, and lead times.
  • The manufacturing process emphasizes purity, stringent quality control, and compliance with regulatory standards.

FAQs

1. Who are the top global suppliers for Naftifine hydrochloride?
Chinese companies such as Juncao Pharmaceutical and Zhejiang Hisun Pharmaceutical are leading suppliers globally.

2. What certifications are required for pharmaceutical-grade Naftifine hydrochloride?
GMP certification is essential; ISO 9001 and ISO 13485 are also recognized for quality management and medical device standards.

3. Is Naftifine hydrochloride patent-protected?
No; it is off-patent, enabling generic manufacturing.

4. Can I source Naftifine hydrochloride for research purposes from the US?
Yes; companies like MedchemExpress provide small quantities suitable for research and development.

5. What are key factors affecting procurement?
Order size, certification compliance, lead times, and supplier capacity influence procurement decisions.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.